Consensus IBEX Limited

Equities

IBEX

BMG4690M1010

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
15.01 USD +3.45% Intraday chart for IBEX Limited -4.88% -21.04%

Evolution of the average Target Price on IBEX Limited

Price target over the last 5 years

History of analyst recommendation changes

87.QeCBMnUTvvYIPmjDrG_wSrTl-saH6Qn6zhux3R9VRlQ.DrTvRTx_9qNFVS2P6yq2L-GilPPrtkiPlijTrnscKGUxosBcA1jLwTlaAw~a63e43a80d566dfc5d97aa108f30b938
RBC Lifts Price Target on IBEX to $19 From $18, Keeps Sector Perform Rating MT
Piper Sandler Downgrades IBEX to Neutral From Overweight, Price Target is $17 MT
Baird Adjusts Price Target on IBEX to $22 From $24, Keeps Outperform Rating MT
Piper Sandler Cuts Price Target on IBEX to $17 From $24, Keeps Overweight Rating MT
Citigroup Adjusts Price Target on IBEX to $18 From $23, Maintains Neutral Rating MT
Baird Adjusts Price Target on IBEX to $24 From $28, Maintains Outperform Rating MT
Truist Securities Adjusts IBEX Price Target to $25 From $32, Maintains Buy Rating MT
IBEX Downgraded by RBC to Sector Perform From Outperform, Price Target Cut to $18 From $27 MT
Piper Sandler Adjusts Price Target on IBEX to $24 From $32, Keeps Overweight Rating MT
Citigroup Adjusts Price Target on IBEX to $23 From $30, Keeps Neutral Rating MT
RBC Cuts Price Target on IBEX to $27 From $30, Citing 'Revenue Growth Pressures,' Decline in Peer Valuations; Outperform Rating Kept MT
Baird Adjusts IBEX Price Target to $28 From $32, Maintains Outperform Rating MT
RBC Raises Price Target on IBEX to $30 From $26, Maintains Outperform Rating MT
Piper Sandler Adjusts Price Target on IBEX to $29 From $27, Maintains Overweight Rating MT
Citigroup Raises Price Target on IBEX to $26 From $18, Maintains Neutral Rating MT
Truist Securities Adjusts IBEX Price Target to $27 From $22, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on IBEX to $27 From $20, Maintains Overweight Rating MT
RBC Raises Price Target on IBEX to $26 From $20, Cites 'Solid Results,' Maintains Outperform Rating MT
Truist Securities Adjusts Price Target on IBEX to $22 From $26, Reiterates Buy Rating MT
Citigroup Adjusts Price Target on IBEX to $18 From $20, Maintains Neutral Rating MT
RBC Cuts Price Target on IBEX to $20 From $22, Maintains Outperform Rating MT
Piper Sandler Trims Price Target on IBEX to $20 From $21, Reiterates Overweight Rating MT
Piper Sandler Adjusts IBEX's Price Target to $21 from $17, Keeps Overweight Rating MT
Piper Sandler Adjusts Price Target on IBEX to $17 From $20, Reiterates Overweight Rating MT
Piper Sandler Adjusts IBEX's Price Target to $20 from $18, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
15.01 USD
Average target price
19.4 USD
Spread / Average Target
+29.25%
High Price Target
22 USD
Spread / Highest target
+46.57%
Low Price Target
17 USD
Spread / Lowest Target
+13.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IBEX Limited

Piper Sandler
RBC Capital Markets
Baird
Citigroup
Truist Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings